PROCARBAZINE | PROCARBAZINE | ATC L01XB01
ANTINEOPLASTIC TREATMENT OF STAGE III AND IV HODGKIN'S DISEASE MAY INHIBIT TRANSMETHYLATION OF METHYL GROUPS OF METHIONINE INTO T-RNA HYDROGEN PEROXIDE FORMED DURING THE AUTO-OXIDATION OF THE DRUG MAY ATTACK PROTEIN SULFHYDRYL GROUPS CONTAINED IN RESIDUAL PROTEIN WHICH IS TIGHTLY BOUND TO DNA | ORAL | Tmax 1 HOUR F 100 PERCENT HT 0.16 HOUR SOLUBILITY SOLUBLE BUT UNSTABLE IN WATER | DNA | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |